Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Myseum.AI, Inc.MYSE · Entity 7833 | Director | August 18, 2025 | August 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Myseum.AI, Inc.
Report date August 18, 2025 · Filed August 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.00 · Expires 2030-08-18 | Direct | 25,000 |
Reported balance
After 2025-08-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-08-18 · Grant · Acquired 25,000 · Balance 25,000 F1: On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2025 Filed Aug 19, 2025 16:31 UTC | Myseum.AI, Inc. MYSE · Entity 7833 | GrantOptions (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001213900-25-078523 · ownership.xml · derivative · entry 1 Shelus Peter · CIK 0001879004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-18 F1 · derivative.exercise_date: On August 18, 2025, the Reporting Person was granted options ("Options") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 17:00 UTC | Myseum.AI, Inc. DATS · Entity 7833 | GrantOptions (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001213900-25-004253 · ownership.xml · derivative · entry 1 Shelus Peter · CIK 0001879004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2035-01-14 F1 · derivative.exercise_date: On January 14, 2025, the Reporting Person was granted options ("Options") to purchase up to 10,000 shares of the Registrant's common stock pursuant to the Registrant's Amended and Restated 2021 Equity Incentive Plan. The Options will vest in four equal installments semiannually, with the first installment vesting six months from the date of issuance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.